NERV Receives Refusal to File Letter from FDA for its NDA for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia…#精神分裂症# 不好开发。
发布于: | Android | 转发:0 | 回复:0 | 喜欢:0 |
NERV Receives Refusal to File Letter from FDA for its NDA for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia…#精神分裂症# 不好开发。